Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges
Jie Lu, Wen Huo, Yingze Ma, et al.
Cancer Letters (2024) Vol. 600, pp. 217185-217185
Open Access | Times Cited: 3
Neutrophils in cancer drug resistance: Roles and therapeutic opportunities
Hao Liu, Hongyu Zhao, Mingzhen Zhou, et al.
Cancer Letters (2024) Vol. 611, pp. 217417-217417
Closed Access | Times Cited: 3
A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity
Young‐Hee Lee, Hyejin Ahn, Hye-In Sim, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies
Yusra Zarlashat, Hafiz Salman Mushtaq, Linh Pham, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6830-6830
Open Access | Times Cited: 2
Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction
Zhiyong Xu, Yueli Shi, Liang Zhu, et al.
Cancer Letters (2024) Vol. 598, pp. 217075-217075
Closed Access | Times Cited: 2
Immunotherapy revolutionizing brain metastatic cancer treatment: personalized strategies for transformative outcomes
Ting Li, Shichen Sun, Yubing Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Self‐Assembled PD‐L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition
Baixue Yu, Yibin Liu, Xia‐Yun Chen, et al.
Small (2024)
Closed Access | Times Cited: 1
Construction and characterization of a novel secreted MsC-CAR-T cell in solid tumors
Yuan Mao, Yufeng Chen, Xiao‐Hui Yang, et al.
Cancer Letters (2024) Vol. 611, pp. 217382-217382
Closed Access | Times Cited: 1
Clinical efficacy and potential mechanism of ginseng polysaccharides in the treatment of non-small cell lung cancer based on meta-analysis associated with network pharmacology
Qi Zhao, Le Bai, Dongwei Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27152-e27152
Open Access | Times Cited: 1
Integrated bioinformatic analysis and experimental validation for exploring the key immune checkpoint of COPD
Junyi Ke, Shu Huang, Zhixiong He, et al.
Gene (2024) Vol. 927, pp. 148711-148711
Closed Access | Times Cited: 1
Localized Ablative Immunotherapy Enhances Antitumor Immunity by Modulating the Transcriptome of Tumor-Infiltrating Gamma Delta T Cells
Kaili Liu, Ashley R. Hoover, Lin Wang, et al.
Cancer Letters (2024), pp. 217267-217267
Open Access | Times Cited: 1
Revisiting the CXCL13/CXCR5 Axis in the Tumor Microenvironment in the Era of Single-cell Omics: Implications for Immunotherapy
Xuanyu Gu, Dongyu Li, Peng Wu, et al.
Cancer Letters (2024), pp. 217278-217278
Open Access | Times Cited: 1
Receptor-Based Strategies for Overcoming Resistance in Cancer Therapy
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
Construction of an Innovative Nanogel and Its Applications for Achieving Chemo-Immunotherapy of Tumors
Sibei Wang, Fan Nie, Zhen Lin, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 44, pp. 59895-59906
Closed Access | Times Cited: 1
Pulsed Electric Field Ablation as a Candidate to Enhance the Anti-Tumor Immune Response to Immune Checkpoint Inhibitors
Blake M Arciga, Dustin M. Walters, Eric T. Kimchi, et al.
Cancer Letters (2024), pp. 217361-217361
Closed Access | Times Cited: 1
Dynamics of Liver Cancer Cellular Taxa Revealed Through Single-cell RNA Sequencing: advances and challenges
Wenxin Li, Huisi He, Hongyang Wang, et al.
Cancer Letters (2024), pp. 217394-217394
Closed Access | Times Cited: 1
Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment
Simona Serratì, Francesca Margheri
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1209-1209
Open Access | Times Cited: 2
O-GlcNAc signaling: Implications for stress-induced adaptive response pathway in the tumor microenvironment
Yu Zhao, Renlong Li, Weizhen Wang, et al.
Cancer Letters (2024) Vol. 598, pp. 217101-217101
Closed Access
Localized Ablative Immunotherapy Enhances Antitumor Immunity by Modulating the Transcriptome of Tumor-Infiltrating Gamma Delta T Cells
Kai‐Li Liu, Ashley R. Hoover, Yuanhong Sun, et al.
(2024)
Closed Access
Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment
Lingpeng Tang, Dandan Wang, Ting Hu, et al.
Cancer Drug Resistance (2024)
Open Access
Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapy
Muhammad Kalim, Rui Jing, Wei Guo, et al.
Cancer Letters (2024) Vol. 606, pp. 217306-217306
Closed Access
An opinion on advanced cancer immunotherapy through innovations in PD-1 inhibitor delivery systems
Piyush Kumar Gupta, Harshita Tiwari, Richa Mishra, et al.
Expert Opinion on Drug Delivery (2024), pp. 1-3
Open Access
MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-β in squamous cell carcinomas with enhanced CD8 T cell memory-driven response
Hanne T. Lind, Spencer C. Hall, Alexander A. Strait, et al.
Cancer Letters (2024), pp. 217347-217347
Closed Access
Regulation and application of m6A modification in tumor immunity
Qunli Xiong, Yaguang Zhang, Zheng Ying, et al.
Science China Life Sciences (2024)
Closed Access
HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors
Mayu Watanabe, Jun Eguchi, Atsushi Takamoto, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access

Scroll to top